UBS maintains a 'Buy' on Merck (NYSE: MRK) price target of $50.00 (from $45.00).

Analyst, Marc Goodman, said, "What ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE